A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma
| Image |  |
|---|---|
| Description | scientific article published on 05 April 2019 |
| Author/s | |
| Publication date | April 5, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |